Network analysis: A way forward for understanding COPD multimorbidity

European Respiratory Journal

Volumn 46, Issue 3, 2015, Pages 591-592

  Faner, Rosa ^a,b   Agustí, Alvar ^a,b,c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGING; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; EDITORIAL; EXERCISE; GASTROESOPHAGEAL REFLUX; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEALTH STATUS; HUMAN; NETWORK ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; FEMALE; INFORMATION SERVICE; MALE; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

COMORBIDITY; FEMALE; HUMANS; INFORMATION SERVICES; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84942762298     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00054815     Document Type: Editorial

References (12)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187: 347-365.
2. Faner R, Cruz T, López-Giraldo A, et al. Network medicine, multimorbidity and the lung in the elderly. Eur Respir J 2014; 44: 775-788.
3. Grosdidier S, Ferrer A, Faner R, et al. Network medicine analysis of COPD multimorbidities. Respir Res 2014; 15: 111.
4. Diez D, Agusti A, Wheelock CE. Network analysis in the investigation of chronic respiratory diseases: from basics to application. Am J Respir Crit Care Med 2014; 190: 981-988.
5. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011; 12: 56-68.
6. Agusti A, Anto JM, Auffray C, et al. Personalized respiratory medicine: exploring the horizon, addressing the issues. Am J Respir Crit Care Med 2015; 191: 391-401.
7. Hidalgo CA, Blumm N, Barabasi AL, et al. A dynamic network approach for the study of human phenotypes. PLoS Comput Biol 2009; 5: e1000353.
8. Divo MJ, Casanova C, Marin JM, et al. COPD comorbidities network. Eur Respir J 2015; 46: 640-650.
9. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 155-161.
10. Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med 2011; 183: 1129-1137.
11. Garcia-Aymerich J, Gomez FP, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66: 430-437.
12. Rennard SI, Locantore N, Delafont B, et al. Identification of five COPD subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc 2015; 12: 303-312.